STOCK TITAN

Surgery Partners, Inc. - $SGRY STOCK NEWS

Welcome to our dedicated page for Surgery Partners news (Ticker: $SGRY), a resource for investors and traders seeking the latest updates and insights on Surgery Partners stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Surgery Partners's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Surgery Partners's position in the market.

Rhea-AI Summary
Surgery Partners, Inc. (NASDAQ:SGRY) reported $674.1 million in Q3 2023 revenues, an 8.6% increase. Adjusted EBITDA was $105.5 million, up 9.7%. Net loss was $4.9 million. Full-year Adjusted EBITDA guidance was raised to $436-440 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.99%
Tags
-
Rhea-AI Summary
Surgery Partners, Inc. to release Q3 2023 results on November 7, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
-
Rhea-AI Summary
Surgery Partners, Inc. (NASDAQ: SGRY) announced its financial results for Q2 2023, reporting revenues of $667.6 million, representing 8.5% growth. Same-facility revenues increased 8.3%, and net income attributable to Surgery Partners was $18.9 million. Adjusted EBITDA was $100.2 million, a 16.4% growth. The company raised its full-year Adjusted EBITDA guidance to greater than $435 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.37%
Tags
Rhea-AI Summary
Surgery Partners, Inc. will release its Q2 2023 results on August 1, 2023, followed by a conference call. Interested investors can join the call or listen to the webcast on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.21%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.61%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.61%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.32%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.69%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.51%
Tags
conferences
Surgery Partners, Inc.

Nasdaq:SGRY

SGRY Rankings

SGRY Stock Data

3.25B
74.36M
1.23%
107.55%
6.54%
General Medical and Surgical Hospitals
Health Care and Social Assistance
Link
United States of America
BRENTWOOD

About SGRY

surgery partners is a leading operator of surgical facilities and ancillary services with more than 180 locations nationwide. we provide exceptional integrated healthcare experiences between our providers and patients. our diverse company operates multiple types of healthcare services dedicated to improving the quality of care in a convenient and cost-effective manner. the support of our ancillary services is one of many unique attributes that differentiate us from our competitors. these services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, optical services and specialty pharmacy services. our integrated approach to advancing markets allows for flexibility to provide care on an individualized, local market basis. whether entering into a new market with surgical facilities, ancillary services or joint ventures with health systems, or furthering an existing market’s growth potential by focusing on base busines